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Soon after the discovery of x-rays in November, 1895, 
by Wilhelm Conrad Röntgen, the first post-mortem 
radiographs were obtained; one example being the 
post-mortem angiography done by Haschek and 
Lindenthal in January, 1896.1 However, it took the 
pioneering work of Richard Dirnhofer and Michael Thali 
with their Virtopsy group to regain wider attention 
for post-mortem radiology and more specifically 
post-mortem CT (PMCT).2 In the past decades, 
substantial progress has been made, although the main 
focus of attention has been on adult forensic PMCT. 
PMCT can have an effect on the diagnosis of the manner 
and cause of death, and it certainly has limitations. 
Most of these limitations are related to the fact that 
the person is no longer alive and thus ventilation and 
circulation have stopped. This fact also implies that a 
normal contrast-enhanced PMCT scan, which clinically 
is routinely acquired, is not possible. To overcome this 
limitation, the use of whole body PMCT angiography 
(wbPMCTA) or focused PMCT angiography (fPMCTA) 
has been advocated.3 A lot of effort has been put into 
the development, use, and validation of multiphase 
wbPMCTA and good results have been shown with a 
dedicated wbPMCTA system.4,5
In the Lancet, Guy N Rutty and colleagues6 report a 
prospective study about the value of PMCTA in natural 
sudden death. For this post-mortem imaging study, 
the primary outcome for large prospective series was 
the accuracy of cause of death, if identifiable on PMCTA 
compared with the autopsy (which they class as gold 
standard). The radiologists reporting the PMCTA, which 
included a precontrast total body PMCT, had access to a 
full report consisting of external examination findings 
and additional medical history. If requested, toxicology 
and biochemistry results were given. This approach has 
previously been named a minimal invasive autopsy.7 
In all these cases in Rutty and colleagues’ study, the 
frequency of PMCTA error was 6% (12 of 193 cases). 
Secondary endpoints were, among others, success of 
procedure (204 of 241, 85%) and identification of a 
cause of death (193 of 210, 92%).
Therefore, the authors show that, in the English 
coronial system, 92% of autopsies could be avoided. 
This approach would not affect overall population cause 
of death data, nor would cases of substantial trauma 
(unnatural cause of death) be missed. How this would 
affect clinical pathology services in other parts of the 
world is unclear.
This study by Rutty and colleagues adds weight 
to the use of PMCTA because it clearly shows the 
feasibility of the technique and the potential effect on 
daily pathological routine. The way this study has been 
designed is reminiscent of the highly acclaimed MaRIAS 
study,7 and we expect that it could have a similar effect 
in the specialty of post-mortem imaging. The success 
of PMCTA in up to 85% of cases, after a learning curve, 
implies that it is feasible to use in a specialised setting. 
The question is whether this success would also be 
attained in a normal setting, where a larger group of 
radiological technicians would be doing the PMCTA 
scans. A second drawback, as acknowledged by Rutty 
and colleagues, is the fact that PMCTA was reported by 
three examiners without any time constraint, which 
would not be feasible in a normal clinical setting.
The study by Rutty and colleagues focused on cause 
of death and individual diagnoses. Many important 
forensic questions concern injury mechanisms, not 
the individual diagnosis, and more research in this 
area is needed. Finally, it would have been interesting 
to know if a limited autopsy or an autopsy limited 
to percutaneous image-guided biopsies would 
have reduced the need for autopsies even further. 
Nevertheless, this study shows that PMCTA is a robust 
and reliable technique, which, if access to a CT scanner 
is available, can be implemented without much financial 
investment in daily pathological practice.
The rapid development of post-mortem imaging will 
continue, and it is possible that methods other than 
CT, such as MRI, will become increasingly important. 
Future research should be aimed at determining which 
combination of post-mortem investigation methods 
are best suited for specific purposes, taking into account 
the aim of the investigation and securing optimal use 
of the available resources. Some difficult cases might 
require an invasive autopsy that follows an enhanced 
algorithm with extensive histological and genetic 
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Achieving universal health coverage is the most 
important means to advance health and wellbeing during 
the next decade. Too many countries—and not only in 
low-income or middle-income settings—do not have a 
health system that provides “access to quality essential 
health-care services and access to safe, effective, quality 
and affordable essential medicines and vaccines for all”, 
as described in Sustainable Development Goal 3.8.1
Even many high-income countries, such as the USA 
and the UK, see important inequalities in income, life 
expectancy, and health outcomes,2,3 and the prevailing 
political and economic landscapes are not encouraging 
for a reversal of this trend in the foreseeable future. At the 
same time, changing demographics in many countries 
mean that the share of the population with two or more 
chronic conditions will increase. As a result, the resilience 
and sustainability of health systems will be put under even 
more pressure. In a recent report by the Organisation for 
Economic Co-operation and Development, it is estimated 
that the proportion of the population in European Union 
countries aged 65 years or older will increase from 20% 
in 2015 to 30% by 2060.4 The same report states that in 
2013, more than 1·2 million people in European Union 
countries died from avoidable illnesses and injuries4—
people who would not have died had there been more 
effective public health and prevention policies in place, or 
more timely and effective health care. Yet all countries are 
struggling with spiralling costs of health and social care, 
with the prospect of rationing and restricting services—a 
strategy that would increase inequality and injustice 
still further. Failure to provide treatment and preventive 
care at all remains the unacceptable reality in many 
low-income and middle-income countries for most of 
their populations. Clearly, something has to change in our 
thinking about the provision of health and health care to 
achieve health and wellbeing for all.
In a Series of papers5–8 and Comments9,10 in The Lancet, 
Vikas Saini and colleagues provide a framework for such 
a change of thinking. The Right Care Series examines the 
areas and extent of overuse and underuse of health and 
medical services around the world. It defines overuse as 
“the provision of medical services that are more likely to 
cause harm than good”,5 and underuse as “the failure to 
use effective and affordable medical interventions”.6 The 
Series authors argue that both overuse and underuse 
happen side-by-side in different countries, within 
countries, among populations, within institutions, 
and even for a single person. This situation offers an 
enormous (and currently poorly recognised) opportunity 
to tackle underuse and overuse together to achieve the 
right care for health and wellbeing.
What is right care? In its simplest definition it is care 
that weighs up benefits and harms, is patient-centred 
(taking individual circumstances, values, and wishes into 
account), and is informed by evidence, including cost-
effectiveness. The Series authors acknowledge that most 
medical services fall into a grey zone where the benefit 
and harm ratio for a given individual is unknown. 
However, an important start is to think about, and 
aim to influence, the drivers of poor, unnecessary, and 
From universal health coverage to right care for health
testing, whereas other cases might be satisfactorily 
investigated with imaging techniques.
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